Comparison of (123)I-Metaiodobenzylguanidine (MIBG) and (131)I-MIBG Semi-Quantitative Scores in Predicting Survival in Patients With Stage 4 Neuroblastoma: A Report From the Children’s Oncology Group

BACKGROUND: (123)I-metaiodobenzylguanidine (MIBG) scans are preferable to (131)I-MIBG for neuroblastoma imaging as they deliver less patient radiation yet have greater sensitivity in disease detection. Both (123)I-MIBG and (131)I-MIBG scans were used for disease assessments of neuroblastoma patients...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pediatr Blood Cancer
Hlavní autoři: Naranjo, Arlene, Parisi, Marguerite T., Shulkin, Barry L., London, Wendy B., Matthay, Katherine K., Kreissman, Susan G., Yanik, Gregory A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4581540/
https://ncbi.nlm.nih.gov/pubmed/21328522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.22991
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky